Key Resources

Infographics and resources on PrEP research, uptake and regulatory status.

Track Global PrEP Use
For insights on the full scope of PrEP use around the world, AVAC’s database of programs delivering oral PrEP, planned, current and completed, offers detailed information, updated quarterly.

global PrEP tracker

Demo and Implementation Studies Table
A summary of ongoing and planned PrEP evaluation studies worldwide.

Regulatory Status of TDF/FTC for PrEP
A summary of countries that have registered TDF/FTC for prevention.

A Global Look at PrEP Introduction
This infographic summarizes the number of PrEP users, demonstration projects and national guidelines worldwide.

PrEP Implementation Tools from Demonstration Projects
Educational and marketing materials, risk assessment tools, user questionnaires, standard operating procedures and more.

Breaking the Cycle of Heterosexual Transmission
An infographic explaining where PrEP, VMMC, ART and other biomedical tools fit in the cycle of heterosexual transmission.

News Spotlight

  • FDA Approves Truvada as PrEP for Adolescents at Risk for HIV

    May 15, 2018

    The US Food and Drug Administration has expanded the approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV to include adolescents. Truvada was approved as an HIV prevention method in 2012 but only for individuals age 18 and older. The new approval expands this indication to include adults and adolescents at risk for HIV.

    Read more

  • Early PrEP Uptake in Africa Study Gives Support for Possibility of Wider Acceptance

    May 9, 2018

    New findings show that nearly a fifth of adults whose risk for HIV infection made them eligible for free PrEP started taking the drug within 30 days — according to a study examining the impacts of health interventions across communities in two East African countries. The study’s authors conclude that this provides further evidence that widespread roll out of PrEP to individuals at high risks for infection across resource-limited communities is feasible.

    Read more